174 related articles for article (PubMed ID: 17932658)
1. In vivo detection of DNA adducts induced by cisplatin using capillary HPLC-ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster.
García Sar D; Montes-Bayón M; Aguado Ortiz L; Blanco-González E; Sierra LM; Sanz-Medel A
Anal Bioanal Chem; 2008 Jan; 390(1):37-44. PubMed ID: 17932658
[TBL] [Abstract][Full Text] [Related]
2. Relationships between cisplatin-induced adducts and DNA strand-breaks, mutation and recombination in vivo in somatic cells of Drosophila melanogaster, under different conditions of nucleotide excision repair.
García Sar D; Aguado L; Montes Bayón M; Comendador MA; Blanco González E; Sanz-Medel A; Sierra LM
Mutat Res; 2012 Jan; 741(1-2):81-8. PubMed ID: 22108251
[TBL] [Abstract][Full Text] [Related]
3. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
[TBL] [Abstract][Full Text] [Related]
4. On the complexity and dynamics of in vivo Cisplatin-DNA adduct formation using HPLC/ICP-MS.
Ziehe M; Esteban-Fernández D; Hochkirch U; Thomale J; Linscheid MW
Metallomics; 2012 Oct; 4(10):1098-104. PubMed ID: 22986644
[TBL] [Abstract][Full Text] [Related]
5. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
Yamada K; Kato N; Takagi A; Koi M; Hemmi H
Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
[TBL] [Abstract][Full Text] [Related]
6. Quantitative profiling of in vivo generated cisplatin-DNA adducts using different isotope dilution strategies.
García Sar D; Montes-Bayón M; Blanco González E; Sierra LM; Aguado L; Comendador MA; Koellensperger G; Hann S; Sanz-Medel A
Anal Chem; 2009 Dec; 81(23):9553-60. PubMed ID: 19886652
[TBL] [Abstract][Full Text] [Related]
7. Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.
Baskerville-Abraham IM; Boysen G; Troutman JM; Mutlu E; Collins L; Dekrafft KE; Lin W; King C; Chaney SG; Swenberg JA
Chem Res Toxicol; 2009 May; 22(5):905-12. PubMed ID: 19323581
[TBL] [Abstract][Full Text] [Related]
8. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
9. Optimized sample preparation strategy for the analysis of low molecular mass adducts of a fluorescent cisplatin analogue in cancer cell lines by CE-dual-LIF.
Zabel R; Kullmann M; Kalayda GV; Jaehde U; Weber G
Electrophoresis; 2015 Feb; 36(4):509-17. PubMed ID: 25483804
[TBL] [Abstract][Full Text] [Related]
10. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
Farmer PB; Singh R
Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
[TBL] [Abstract][Full Text] [Related]
11. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.
Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR
Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436
[TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of DNA adducts using liquid chromatography/electrospray ionization mass spectrometry and liquid chromatography/high-resolution inductively coupled plasma mass spectrometry.
Siethoff C; Feldmann I; Jakubowski N; Linscheid M
J Mass Spectrom; 1999 Apr; 34(4):421-6. PubMed ID: 10226366
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry of cis-diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trap.
Hagemeister T; Linscheid M
J Mass Spectrom; 2002 Jul; 37(7):731-47. PubMed ID: 12125006
[TBL] [Abstract][Full Text] [Related]
14. Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA.
Meczes EL; Azim-Araghi A; Ottley CJ; Pearson DG; Tilby MJ
Biochem Pharmacol; 2005 Dec; 70(12):1717-25. PubMed ID: 16259963
[TBL] [Abstract][Full Text] [Related]
15. Reduction of cisplatin-induced nephrotoxicity in vivo by selenomethionine: the effect on cisplatin-DNA adducts.
García Sar D; Montes-Bayón M; Blanco González E; Sierra Zapico LM; Sanz-Medel A
Chem Res Toxicol; 2011 Jun; 24(6):896-904. PubMed ID: 21491944
[TBL] [Abstract][Full Text] [Related]
16. Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin.
Brouwers EE; Tibben MM; Pluim D; Rosing H; Boot H; Cats A; Schellens JH; Beijnen JH
Anal Bioanal Chem; 2008 May; 391(2):577-85. PubMed ID: 18385987
[TBL] [Abstract][Full Text] [Related]
17. Analysis of DNA adduct, S-[2-(N7-guanyl)ethyl]glutathione, by liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry.
Huang H; Jemal A; David C; Barker SA; Swenson DH; Means JC
Anal Biochem; 1998 Dec; 265(1):139-50. PubMed ID: 9866718
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of melphalan DNA adducts using HPLC - inductively coupled mass spectrometry.
Edler M; Jakubowski N; Linscheid M
J Mass Spectrom; 2006 Apr; 41(4):507-16. PubMed ID: 16541389
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of cellular uptake, DNA incorporation and adduct formation in cisplatin sensitive and resistant cell lines: Comparison of different Pt-containing drugs.
Corte-Rodríguez M; Espina M; Sierra LM; Blanco E; Ames T; Montes-Bayón M; Sanz-Medel A
Biochem Pharmacol; 2015 Nov; 98(1):69-77. PubMed ID: 26352094
[TBL] [Abstract][Full Text] [Related]
20. Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes.
Jones CR; Sabbioni G
Chem Res Toxicol; 2003 Oct; 16(10):1251-63. PubMed ID: 14565767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
